Also known as: Cibinetide
ARA-290, also known as C16H24N4O4S, is a peptide categorized under Healing & Recovery Peptides. It is recognized primarily as an innate repair receptor (IRR) agonist, which plays a crucial role in cellular repair processes. This peptide is synthesized to mimic the body's natural mechanisms for healing and recovery, making it a subject of interest in various research fields.
ARA-290 is designed to activate the innate repair receptor, which is involved in the regulation of inflammation and tissue repair. Its unique structure allows it to interact effectively with the IRR, promoting beneficial cellular responses that can aid in recovery from injury and disease.
ARA-290 functions by binding to the innate repair receptor (IRR), which is found on the surface of various cell types. This interaction triggers a cascade of intracellular signaling pathways that enhance the body's natural healing processes.
Upon activation of the IRR, ARA-290 promotes the release of anti-inflammatory cytokines and growth factors, which are essential for tissue regeneration. This mechanism not only helps in reducing inflammation but also supports the repair of damaged tissues, making it a valuable peptide in therapeutic research.
ARA-290 is a peptide that acts as an innate repair receptor agonist, facilitating healing and recovery through its anti-inflammatory and regenerative properties. Its ongoing research highlights its potential applications in various therapeutic areas, particularly in pain management and tissue repair.
Last updated: Feb 25, 2026